TY - JOUR
T1 - Innovative strategies for the elimination of viral hepatitis at a national level
T2 - a country case series
AU - Schröeder, Sophia E.
AU - Pedrana, Alisa
AU - Scott, Nick
AU - Wilson, David
AU - Kuschel, Christian
AU - Aufegger, Lisa
AU - Atun, Rifat
AU - Baptista-Leite, Ricardo
AU - Butsashvili, Maia
AU - El-Sayed, Manal
AU - Getahun, Aneley
AU - Hamid, Saeed
AU - Hammad, Radi
AU - ‘t Hoen, Ellen
AU - Hutchinson, Sharon J.
AU - Lazarus, Jeffrey V.
AU - Lesi, Olufunmilayo
AU - Li, Wangsheng
AU - Binti Mohamed, Rosmawati
AU - Olafsson, Sigurdur
AU - Peck, Raquel
AU - Sohn, Annette H.
AU - Sonderup, Mark
AU - Spearman, Catherine W.
AU - Swan, Tracy
AU - Thursz, Mark
AU - Walker, Tim
AU - Hellard, Margaret
AU - Howell, Jessica
PY - 2019/10/1
Y1 - 2019/10/1
N2 - Viral hepatitis is a leading cause of morbidity and mortality worldwide, but has long been neglected by national and international policymakers. Recent modelling studies suggest that investing in the global elimination of viral hepatitis is feasible and cost-effective. In 2016, all 194 member states of the World Health Organization endorsed the goal to eliminate viral hepatitis as a public health threat by 2030, but complex systemic and social realities hamper implementation efforts. This paper presents eight case studies from a diverse range of countries that have invested in responses to viral hepatitis and adopted innovative approaches to tackle their respective epidemics. Based on an investment framework developed to build a global investment case for the elimination of viral hepatitis by 2030, national activities and key enablers are highlighted that showcase the feasibility and impact of concerted hepatitis responses across a range of settings, with different levels of available resources and infrastructural development. These case studies demonstrate the utility of taking a multipronged, public health approach to: (a) evidence-gathering and planning; (b) implementation; and (c) integration of viral hepatitis services into the Agenda for Sustainable Development. They provide models for planning, investment and implementation strategies for other countries facing similar challenges and resource constraints.
AB - Viral hepatitis is a leading cause of morbidity and mortality worldwide, but has long been neglected by national and international policymakers. Recent modelling studies suggest that investing in the global elimination of viral hepatitis is feasible and cost-effective. In 2016, all 194 member states of the World Health Organization endorsed the goal to eliminate viral hepatitis as a public health threat by 2030, but complex systemic and social realities hamper implementation efforts. This paper presents eight case studies from a diverse range of countries that have invested in responses to viral hepatitis and adopted innovative approaches to tackle their respective epidemics. Based on an investment framework developed to build a global investment case for the elimination of viral hepatitis by 2030, national activities and key enablers are highlighted that showcase the feasibility and impact of concerted hepatitis responses across a range of settings, with different levels of available resources and infrastructural development. These case studies demonstrate the utility of taking a multipronged, public health approach to: (a) evidence-gathering and planning; (b) implementation; and (c) integration of viral hepatitis services into the Agenda for Sustainable Development. They provide models for planning, investment and implementation strategies for other countries facing similar challenges and resource constraints.
KW - Developing countries
KW - Disease elimination
KW - Hepatitis B
KW - Hepatitis C
KW - Investment case
KW - Organizational case studies
UR - http://www.scopus.com/inward/record.url?scp=85071771046&partnerID=8YFLogxK
U2 - 10.1111/liv.14222
DO - 10.1111/liv.14222
M3 - Review article
C2 - 31433902
AN - SCOPUS:85071771046
VL - 39
SP - 1818
EP - 1836
JO - Liver International
JF - Liver International
SN - 1478-3223
IS - 10
ER -
